The human myelomonocytic cell line, THP-1, was ordered from the American Type Culture Collection (ATCC, TIB-202). Cells were maintained in RPMI 1640/Glutamax-I media (Gibco BRL, Bleiswijk, The Netherlands) supplemented with 10% heat-inactivated fetal calf serum (Gibco, Bleiswijk, The Netherlands) plus penicillin G (100 U/mL) and streptomycin (100 g/mL). THP-1 cells were differentiated to macrophages after their treatment with 20 ng/mL phorbol 12-myristate 7-acetate (PMA) (Sigma, St. Louis, MO, USA) for 48 h at 37 °C, 5% CO2. The viability of THP-1 mature macrophage-like cells was determined to be >97% by the Trypan blue dye exclusion assay.
Rpmi 1640 glutamax 1 media
RPMI 1640/Glutamax-I media is a cell culture medium designed to support the growth and maintenance of a variety of cell types. It provides essential nutrients, including amino acids, vitamins, and salts, to create an optimal environment for cell proliferation and differentiation. The medium is supplemented with Glutamax-I, a stable glutamine substitute, which helps maintain cell health and viability.
Lab products found in correlation
2 protocols using rpmi 1640 glutamax 1 media
Leishmania Infection Assay in THP-1 Macrophages
The human myelomonocytic cell line, THP-1, was ordered from the American Type Culture Collection (ATCC, TIB-202). Cells were maintained in RPMI 1640/Glutamax-I media (Gibco BRL, Bleiswijk, The Netherlands) supplemented with 10% heat-inactivated fetal calf serum (Gibco, Bleiswijk, The Netherlands) plus penicillin G (100 U/mL) and streptomycin (100 g/mL). THP-1 cells were differentiated to macrophages after their treatment with 20 ng/mL phorbol 12-myristate 7-acetate (PMA) (Sigma, St. Louis, MO, USA) for 48 h at 37 °C, 5% CO2. The viability of THP-1 mature macrophage-like cells was determined to be >97% by the Trypan blue dye exclusion assay.
Enhancing Antigen-Specific T-Cell Responses
Example 17
B7-H1 interaction with PD-1 has been shown to inhibit antigen specific T-cell responses. In order to assess the effect of anti-B7-H1 antibodies on this inhibition a sub-optimal antigen recall assay was performed.
Peripheral blood monocytes (PBMCs) were isolated from human blood buffy coats using Ficoll-Paque Plus (GE Healthcare 17-1440-03) density gradient centrifugation as per manufacturers instructions. Following isolation cells were resuspended in RPMI 1640 Glutamax I media (GIBCO, □61870) supplemented with 1% pen/strep (GIBCO, □15140) and 4% Human AB Serum (Invitrogen □34005), and then subsequently cultured in 96 well, round bottom tissue culture plates (Corning, □3799) at 370 C, 5% CO2, with or without 0.1 μg/mL tetanus toxoid (Calbiochem □582231) at a density of 1×105 cells per well. After three days of culture, anti-B7-H1 antibodies in the IgG1-TM format or isotype control were added at the indicated concentrations and cultures returned to 37° C. for a further 2 days, at which point supernatants were harvested and analysed by DELFIA for levels of interferon-γ. Enhancement of interferon-γ release by anti-B7-H1 antibodies is shown in
Anti-B7-H1 antibodies 2.9D10, 2.7A4OPT and 2.14H9OPT are able to increase the release of Interferon-γ. This data confirms the ability of 2.9D10, 2.7A4OPT and 2.14H9OPT to enhance antigen specific T-cell responses.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!